Condition: Colorectal Cancer · Diverticulitis, Colonic · Inflammatory Bowel Diseases · Sponsor: Claus Anders Bertelsen, PhD, MD
This observational study aims to test proteomics, metabolomics and proteoglycans as predictors of postoperative complications after colorectal surgery and as biomarkers of colorectal cancer. The main questions to answer are: * can these biomarkers predict anastomotic leakages * can these biomarkers predict recurrence after colorectal cancer * can these biomarkers be used as diagnostic tests for colorectal cancer * can these biomarkers be identified in the tumor Participants will undergo elective colorectal resection or stoma closure.
This description comes directly from the study's public registry record.
Nanna B Hupfeld, ph.d. · +4548292793 · nanna.baekvang.hupfeld.01@regionh.dk
Always discuss trial participation with your own doctor first.
| Nordsjaellands Hospital | Hillerød, Denmark | Recruiting |
| Regionshospitalet Viborg | Viborg, Denmark | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06287671